JOSEPH M ORTENBERG

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease FORT WORTH, TX NPI 1881682607

General Payments — all program years on this page

$5,134.59

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 283
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $731.29 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $731.2937

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,346.5363
2019 $1,192.5883
2020 $463.2332
2021 $264.8618
2022 $242.8615
2023 $893.2435
2024 $731.2937

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087245765 Novartis Pharmaceuticals Corporation $19.44 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087245769 Novartis Pharmaceuticals Corporation $16.93 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087245771 Novartis Pharmaceuticals Corporation $26.47 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087245773 Novartis Pharmaceuticals Corporation $19.33 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087245775 Novartis Pharmaceuticals Corporation $22.24 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087245779 Novartis Pharmaceuticals Corporation $20.50 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808714 E.R. Squibb & Sons, L.L.C. $26.10 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808725 E.R. Squibb & Sons, L.L.C. $15.35 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808759 E.R. Squibb & Sons, L.L.C. $19.70 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808795 E.R. Squibb & Sons, L.L.C. $5.66 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808799 E.R. Squibb & Sons, L.L.C. $23.13 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808818 E.R. Squibb & Sons, L.L.C. $22.60 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808821 E.R. Squibb & Sons, L.L.C. $22.34 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808847 E.R. Squibb & Sons, L.L.C. $19.81 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808851 E.R. Squibb & Sons, L.L.C. $16.57 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101808866 E.R. Squibb & Sons, L.L.C. $20.65 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111666542 Amgen Inc. $13.61 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118211931 Boehringer Ingelheim Pharmaceuticals, Inc. $14.45 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118211935 Boehringer Ingelheim Pharmaceuticals, Inc. $14.99 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118211939 Boehringer Ingelheim Pharmaceuticals, Inc. $16.06 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118211943 Boehringer Ingelheim Pharmaceuticals, Inc. $19.51 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119531027 Medtronic, Inc. $55.03 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120665044 Baxter Healthcare $19.06 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125319855 Abbott Laboratories $14.54 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131267501 PFIZER INC. $20.52 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131462173 PFIZER INC. $21.37 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131489583 PFIZER INC. $21.27 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131851915 PFIZER INC. $18.98 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139621027 SANOFI-AVENTIS U.S. LLC $16.20 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141697438 Merck Sharp & Dohme LLC $17.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141697602 Merck Sharp & Dohme LLC $21.67 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146907677 Philips North America LLC $21.49 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146907679 Philips North America LLC $19.54 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146907681 Philips North America LLC $18.60 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154880901 Kiniksa Pharmaceuticals International, plc $16.48 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154880947 Kiniksa Pharmaceuticals International, plc $18.97 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881017 Kiniksa Pharmaceuticals International, plc $14.48 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.